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Persistent Human 
Metapneumovirus 
Infection in 
Immunocom-
promised Child 
To the Editor: Respiratory vi-
ral infections can be associated with 
a wide range of clinical manifesta-
tions from self-limiting upper respira-
tory tract diseases to pneumonia (1). 
However, in general, respiratory viral 
infections are more likely to progress 
to more severe diseases in immmu-
nocompromised patients. Human 
metapneumovirus (hMPV) has been 
reported in most parts of the world as 
a cause of acute respiratory tract in-
fections in persons of all age groups 
(2). Fatal hMPV infections have been 
reported in immunocompromised pa-
tients, including a 17-month-old girl 
who had acute lymphoblastic leuke-
mia (3) and a 33-year-old woman who 
had received a hematopoietic stem 
cell transplant (HSCT) (4). In adult 
HSCT recipients, fatal pneumonia (5) 
and persistent hMPV infection with-
out respiratory symptoms have been 
described (6). In addition, adult lung 
transplant recipients have been able 
to clear hMPV infection despite high 
levels of immunosuppression (7). We 
report a case of persistent hMPV infec-
tion in a child with severe combined 
immunodeﬁ   ciency disorder (SCID) 
who shed hMPV during an 11-month 
period.
The child, a girl who was born in 
January 2002, received an allogeneic 
haploidentical stem cell transplant 
from her father in May 2002 after 
her diagnosis of SCID. Infection with 
inﬂ  uenza A virus (H3N2) was diag-
nosed on April 2005 and progressed 
to a chronic pneumonitis of the lin-
gula. She received successive courses 
of anti-inﬂ  uenza agents (amantadine, 
oseltamivir, and zanamivir) for 1 year 
during which time several positive 
inﬂ  uenza cultures were obtained (8). 
Four years after the transplant, she 
was still lymphopenic (800 × 109/L, 
mostly T cells) and had chronic graft-
versus-host disease, which had been 
treated with steroids (prednisone 2.5 
mg twice a day for many months). She 
also had a mild chronic cough but did 
not need supplemental oxygen while 
she was receiving nebulized zana-
mivir (10–20 mg twice a day). Her 2 
nasopharyngeal aspirate (NPA) speci-
mens from June and July 2006 were 
negative for inﬂ  uenza virus. However, 
positive cultures for hMPV were ob-
tained from NPA and bronchoalveolar 
lavage specimens collected on July 
2006. After receiving this result, we 
performed retrospective and prospec-
tive molecular detection studies for 
hMPV for this patient. HMPV was de-
tected by reverse transcription–PCR 
for the F and G genes (9) in 6 and 7 
NPA samples, respectively, collected 
during an 11-month period from No-
vember 4, 2005, through October 4, 
2006. These samples were obtained 
for surveillance of inﬂ  uenza infection 
in this child with persistent cough.
Ampliﬁ   ed hMPV G sequences 
were aligned by using the Clustal
W program (www.molecularevolution.
org/cdc/software/clustalw). A phylo
genetic tree was constructed with 
MEGA 3.1 software (www.megasoft
ware.net) by using the neighbor-
joining algorithm with Kimura-2 
parameters. Sequence analysis of the 
hMPV G gene showed that all strains 
belonged to the B2 genotype, which 
clustered with hMPV Can98–75 and 
NL1/94 reference strains (Figure, 
panel A). Ampliﬁ  ed hMPV G gene 
sequences of the 6 samples collected 
in 2006 were identical, but they had 
96.7% and 92.8% nucleotide  and 
amino acid identities, respectively, 
with the initial strain from November 
2005, which clearly indicates 2 viral 
strains (Figure, panel B). Similar re-
sults were obtained with the F gene 
(data not shown). Inoculation of the 
respiratory samples on a panel of 10 
cell lines as previously described (10) 
showed that only 2 of 7 NPA samples 
were positive for hMPV by culture; 
2 of the 5 remaining samples were 
positive for inﬂ  uenza A, which may 
have masked the cytopathic effects 
of hMPV on rhesus monkey kidney 
(LLC-MK2) cells.
Persistent hMPV infection in 
asymptomatic adult HSCT recipients 
has been described (6). In that study, 
hMPV was isolated from 2 patients in 
2 consecutive samples collected 12–56 
days apart. However, virus evolution 
was not adequately investigated be-
cause it was based on sequence anal-
ysis of a 150-bp fragment from the 
highly conserved nucleoprotein gene 
(6). Unlike in previous reports (6,7), 
characterization of hMPV strains in 
our study was performed by sequence 
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analysis of a 633-bp fragment from 
the most variable hMPV G gene. Our 
ﬁ  ndings showed 2 distinct hMPV vari-
ants of the same genotype (B2). These 
variants might represent a viral drift 
after immune pressure but most likely 
was the result of 2 different infections 
in the immunocompromised child. 
The latter hypothesis is suggested by 
the considerable amino acid variability 
(15 aa differences in the 211-aa region 
of the G protein) between strains col-
lected on November, 4, 2005, and Jan-
uary, 20, 2006, compared with identi-
cal sequences for the strains recovered 
over the next 10 months. Debiaggi et 
al. (6) previously suggested that per-
sistent hMPV infection in HSCT pa-
tients was attributable to their inability 
to clear the virus because of impaired 
immune response. By contrast, adult 
lung transplant recipients were found 
to be able to achieve hMPV clearance 
despite their severe immunosuppres-
sion status (7). Because both fatal and 
mild or asymptomatic hMPV infec-
tions have been reported in immuno-
compromised hosts, additional studies 
are needed to determine whether such 
differing outcomes  are due to viral, 
host, or environmental factors. In con-
clusion, this case of persistent hMPV 
infection associated with relatively 
mild respiratory symptoms in an im-
munocompromised child suggests that 
the host’s immune response may play 
a key role in disease pathogenesis.
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Figure. A) Phylogenetic analysis of human metapneumovirus (hMPV) strains isolated 
during an 11-month period based on nucleotide sequences of the G gene. Multiple 
nucleotide sequence alignments were performed by using the ClustalW program (www.
molecularevolution.org/cdc/software/clustalw); a phylogenetic tree was constructed with 
MEGA 3.1 software (www.megasoftware.net) by using the neighbor-joining algorithm 
with Kimura-2 parameters. The analysis included the following hMPV reference strains: 
Can98/75 (GenBank accession no. AY485245), NL1/94 (AY304362), NL1/99 (AY304361), 
NL1/00 (AF371337), NL17/00 (AY304360), and Can97/83 (AY485253). Scale bar indicates 
1 substitution for every 10 nucleic acid residues. Boldface indicates reference isolates. 
B) Comparison of the partial amino acid sequences (residues 26–236) of the G protein of 
hMPV isolates recovered during an 11-month period from an immunocompromised child. 
Asterisks denote identical residues; shaded boxes highlight different amino acids between 
the hMPV variant of November 4, 2005, and the subsequent variants from January 20, 
2006, to October 4, 2006. LETTERS
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Leptospirosis in 
Taiwan, 2001–2006
To the Editor: Leptospirosis is 
a zoonotic disease that has now been 
identiﬁ  ed  as an emerging infectious 
disease (1,2). It is caused by pathogen-
ic spirochetes of the genus Leptospira. 
The natural hosts for Leptospira spp. 
come from a variety of species (2–4), 
of which the rodent is the most impor-
tant reservoir (4,5). The incubation pe-
riod range for leptospirosis is usually 
5–14 days, with a range of 2–30 days 
(4). Leptospirosis is a disease of humid 
tropical and subtropical countries. Ac-
cording to the World Health Organiza-
tion (4), probable leptospirosis inci-
dence ranges from ≈0.1–1 case/100,000 
population/year in temperate climates 
to 10–100 cases/100,000 population/
year in humid tropical climates. Lep-
tospirosis epidemics are often related 
to heavy rainfall and ﬂ  ooding (1,6,7). 
Because of its climate, Taiwan may be 
at high risk for leptospirosis. We there-
fore investigated human leptospirosis 
in Taiwan and the relationship between 
leptospirosis incidence and rainfall 
pattern. 
Taiwan is a medium-sized archi-
pelago in East Asia; the Tropic of Can-
cer runs through its center. The north-
ern part of Taiwan is subtropical; the 
southern part is tropical. Taiwan lies in 
the path of many tropical storms and 
typhoons that bring extremely heavy 
rainfall usually during July–Septem-
ber. The annual “plum rain” season in 
May and June also brings a lot of pre-
cipitation. Because of its tropical and 
subtropical marine climate, Taiwan 
enjoys rich agricultural productivity 
throughout the year, which is favor-
able for rodent infestations (8,9). 
In Taiwan, reported cases of lep-
tospirosis have been investigated by 
the Centers for Disease Control since 
2001. Leptospirosis should be sus-
pected in patients who have fever; 
headache; myalgia; abdominal pain; 
prostration; conjunctival suffusion; 
meningeal irritation and aseptic men-
ingitis; anuria, oliguria, or proteinuria; 
jaundice; acute renal insufﬁ  ciency; or 
gastrointestinal or lung hemorrhage. 
Patients with suspected leptospirosis 
are reported by physicians to Taiwan’s 
Centers for Disease Control through 
the Notiﬁ   able Disease Surveillance 
System, after which local health bu-
reaus collect urine and blood samples 
for conﬁ  rmation by serologic testing. 
Urine and blood samples from patients 
with clinically suspected leptospiro-
sis are inoculated into Ellinghausen-
McCullough-Johnson-Harris culture 
medium plus 5-ﬂ   uorouracil and in-
cubated at 30°C for 8–12 weeks. 
Cultures are examined by dark-ﬁ  eld 
microscopy every week. Alternative-
ly, latex agglutination assay may be 
used for rapid serologic diagnosis of 
serum from patients with clinically 
suspected leptospirosis (10). Samples 
with positive latex agglutination assay 
results should be conﬁ  rmed by micro-
scopic agglutination test (MAT). An 
antibody titer >100 as determined by 
MAT is regarded as a probable case of 
leptospirosis. The local health bureau 
again collects patients’ serum during 
the convalescent phase of illness for 
conﬁ  rmation by MAT. A laboratory-
conﬁ  rmed case is deﬁ  ned as the iso-
lation of leptospires from urine and 
blood or a 4-fold increase in antibody 
titer between acute- and convalescent-
phase samples.
During 2001–2006, of 7,733 sus-
pected human cases of leptospirosis, 
291 cases were conﬁ  rmed. The major 
serotype identiﬁ  ed was L. santarosai 
serovar Shermani. The mean annual 
incidence was 0.21 cases/100,000 
population. The laboratory-conﬁ  rmed 
cases were observed in Taiwan, most-
ly in male patients (83.5%) (Figure, 
panel A). Cases occurred in all age 
groups but were more common (90%) 
in those 25–74 years of age. Age-spe-
ciﬁ  c incidence was highest for persons 
55–64 years of age; mean annual inci-
dence was 0.57/100,000 population.
Rainfall data from the Central 
Weather Bureau of the Republic of 
China showed typically high rain-
fall (252–433 mm/month) in Taiwan 
during May–September. Heavy rains 
were followed by an increase in lab-
oratory-conﬁ  rmed cases of leptospiro-
sis (Figure, panel B); June–October 
accounted for 60% of cases, with 
a higher incidence of 0.022–0.028 
cases/100,000 population. In Octo-
ber–December, monthly rainfall was 
below average (201.1 mm/month), 
but leptospirosis incidence was above 
average (0.018/100,000). Speciﬁ  cally, 
25 (74%) of leptospirosis cases in Oc-
tober, 10 (42%) in November, and 4 
(19%) in December were likely as-
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